The Academy of Physicians in Clinical Research concluded its annual meeting at the University of North Florida in Jacksonville Nov. 2. Among the many items of business, APCR president Michael Koren, MD, CPI, FAPCR, passed the torch of leadership to Cara East, MD, FACP, FAPCR.
“I could not be more excited about her ascension,” said Koren. “Dr. East is a highly accomplished academic cardiologist. She will bring a leadership style of smarts and persistence that will serve the APCR well.”
Dr. East has been involved in clinical trial research since 1987, working as a principal investigator for over 70 trials. She has also participated as a subinvestigator in more than 20 trials. Such studies have included the use of stem cells in cardiomyopathy and as an adjunct to heart surgery, studies of renal artery nerve ablation as an alternative treatment for hypertension, the use of mipomersen and the PCSK9 inhibitors in familial hypercholesterolemia, the development of novel oral anticoagulants for the prevention of thromboembolic events in atrial fibrillation, the need for repeat ablation following cryoablation for atrial fibrillation and the gender of authors in a local journal. She has over 48 articles published in peer-reviewed journals and serves as a reviewer for several journals. She is currently a clinical professor at Texas A&M College of Medicine and a cardiology staff attending for Baylor University Medical Center Internal Medicine teaching program. She served on a general medicine IRB and as the cardiologist on an oncology IRB. She currently is a National Leader of the Paradise trial and is the chairman of the Data Safety Monitoring Committee for the NIH trial “Exercise and intensive vascular risk reduction in preventing dementia.”
An active APCR member since 2015, we congratulate Dr. East on her new leadership role.